search
Back to results

An Enhanced Protein (Dairy) Weight Loss Intervention for Dynapenic Obesity: Impact on Muscle Quality and Composition (DDYNAMO)

Primary Purpose

Dynapenia, Obesity

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Weight Loss
Dairy Protein
Low intensity exercise
Sponsored by
Duke University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dynapenia

Eligibility Criteria

60 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • BMI >30;
  • SPPB score of ≥4 to <10;
  • GFR <45 mL/min

Exclusion Criteria:

  • Body weight >495 lbs. (BodPod limits);
  • estimated glomerular filtration rates (eGFR) less than 45 mL/min;
  • symptomatic cardiac disease;
  • receiving chemotherapy;
  • hemophilia;
  • presence of unstable or symptomatic life-threatening illness;
  • neurological disease or disorder causing functional impairments;
  • inability to walk,
  • dementia;
  • prescription weight loss medications;
  • use of monamine oxidase inhibitors (MAOIs); or
  • primary medical provider advises against participation.

Sites / Locations

  • Duke University Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Active Comparator

Arm Label

WL-LoEX

Pro-WL-LoEX

Arm Description

10% Weight loss diet plus low intensity exercise (protein ~0.8g/kg). Participants will be provided one serving of dairy protein daily.

Protein-enhanced 10% Weight loss diet plus low intensity exercise (protein ~1.2 g/kg with > 30g per meal and >60% as dairy). Participants will be provided at least 8 servings of dairy protein daily.

Outcomes

Primary Outcome Measures

Change in muscle quality
composite score of time to perform ten chair rises, height of the chair, leg length, body mass, and acceleration of gravity in relation to muscle mass
Change in muscle adipose infiltration
CT-scan

Secondary Outcome Measures

Change in Physical Function
short physical performance battery score
Change in Body weight
change in weight
Change in lean Body Mass
BodPod
Change in lean Body Mass
DEXA
Change in fat mass
BodPod
Change in fat mass
DEXA
Change in 6-minute walk time
6-minute walk
Change in 8-foot up and go time
time it takes to complete 8-foot up and go
Change in 30 second chair stands
number of chair stands done in 30 seconds
Change in dietary protein intake
3-day food record
Change in calorie intake
3-day food record
Change in Bone Mineral Density
DEXA
Change in sleep
Pittsburgh sleep quality index
Change in depression
Center for Epidemiologic Studies Depression Scale
Change in hand grip strength
Jamar Hand Dynamometer
Change in physical activity
Community Health Activities Model Program for Seniors (CHAMPS)
Change in physical activity
Actigraph - accelerometer
Change in quality of life
SF-36

Full Information

First Posted
May 5, 2015
Last Updated
November 6, 2018
Sponsor
Duke University
Collaborators
Dairy Research Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT02437643
Brief Title
An Enhanced Protein (Dairy) Weight Loss Intervention for Dynapenic Obesity: Impact on Muscle Quality and Composition
Acronym
DDYNAMO
Official Title
An Enhanced Protein (Dairy) Weight Loss Intervention for Dynapenic Obesity: Impact on Muscle Quality and Composition
Study Type
Interventional

2. Study Status

Record Verification Date
November 2018
Overall Recruitment Status
Completed
Study Start Date
August 17, 2015 (Actual)
Primary Completion Date
October 15, 2018 (Actual)
Study Completion Date
October 15, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Duke University
Collaborators
Dairy Research Institute

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of the trial is to assess the effects of combining regular, generous intakes of high quality protein (primarily from dairy and other animal source proteins) with calorie restriction and low-intensity exercise on muscle quality and muscle adipose infiltration (along with bone mineral density [BMD] and a number of secondary outcomes) in frail, obese, older adults participating in a 6 month intervention. The investigators will compare these effects to those of a traditional control regimen of calorie restriction and low-intensity exercise over the same duration.
Detailed Description
Obese older adults (≥60 yrs) with moderate functional impairment will be randomized to 1 of 2 study arms. Outcomes to be measured at 0, 3 and 6 months are as follows: Primary outcomes- (1) Muscle Quality (MQ): muscle power (time to perform ten chair rises, height of the chair, leg length, body mass, and acceleration of gravity) in relation to muscle mass (CT-scan) and (2) Muscle adipose infiltration (MAI) (CT-scan). Secondary outcomes- Bone Mineral Density (BMD; DXA scan) physical function (Short Physical Performance Battery (SPPB); 6 minute walk; 8-foot up and go; and 30 second chair stands; handgrip strength; body weight; fat mass; waist circumference; activity (accelerometers); mental health (sleep, depression, quality of life); and feasibility factors (adherence, protein intake, nutrition adequacy). BMD will only be accessed at 0 and 6 months. Study Arms: Weight loss plus low-intensity exercise intervention (WL-LoEX; n = 35): Subjects follow a calorie-reduction diet for a weight loss of ≥10%, protein~0.8g/g/d. Subjects will also participate in three 30-minute low-intensity exercise sessions weekly. One serving of dairy protein/day will be provided to WL-LoEX participants. High protein weight loss plus low-intensity exercise intervention (PRO-WL-LoEX; n = 35): Subjects follow a calorie-reduction diet for a weight loss of ≥10%, with a high proportion of high quality protein at each meal. Intakes of > 30g of protein will be achieved three times a day by subjects in this group, with all or predominantly all from animal sources (high quality) and 60-70% of animal protein from dairy foods that will be provided. Subjects will also participate in three 30-minute low-intensity exercise sessions weekly.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dynapenia, Obesity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
81 (Actual)

8. Arms, Groups, and Interventions

Arm Title
WL-LoEX
Arm Type
Placebo Comparator
Arm Description
10% Weight loss diet plus low intensity exercise (protein ~0.8g/kg). Participants will be provided one serving of dairy protein daily.
Arm Title
Pro-WL-LoEX
Arm Type
Active Comparator
Arm Description
Protein-enhanced 10% Weight loss diet plus low intensity exercise (protein ~1.2 g/kg with > 30g per meal and >60% as dairy). Participants will be provided at least 8 servings of dairy protein daily.
Intervention Type
Behavioral
Intervention Name(s)
Weight Loss
Intervention Description
Participants will be prescribed hypo-caloric diet prescription.
Intervention Type
Dietary Supplement
Intervention Name(s)
Dairy Protein
Intervention Description
Participants will be provided dairy products: WL-LoEx will be provided 1 dairy serving per day and Pro-WL-LoEx will be provided 8 dairy servings per day.
Intervention Type
Behavioral
Intervention Name(s)
Low intensity exercise
Intervention Description
Participants in both groups will participate in chair exercises 3 times a week.
Primary Outcome Measure Information:
Title
Change in muscle quality
Description
composite score of time to perform ten chair rises, height of the chair, leg length, body mass, and acceleration of gravity in relation to muscle mass
Time Frame
baseline, 3 months, 6 months
Title
Change in muscle adipose infiltration
Description
CT-scan
Time Frame
baseline, 3 months, 6 months
Secondary Outcome Measure Information:
Title
Change in Physical Function
Description
short physical performance battery score
Time Frame
baseline, 3 months, 6 months
Title
Change in Body weight
Description
change in weight
Time Frame
baseline, 3 months, 6 months
Title
Change in lean Body Mass
Description
BodPod
Time Frame
baseline, 3 months, 6 months
Title
Change in lean Body Mass
Description
DEXA
Time Frame
baseline, 3 months, 6 months
Title
Change in fat mass
Description
BodPod
Time Frame
baseline, 3 months, 6 months
Title
Change in fat mass
Description
DEXA
Time Frame
baseline, 3 months, 6 months
Title
Change in 6-minute walk time
Description
6-minute walk
Time Frame
baseline, 3 months, 6 months
Title
Change in 8-foot up and go time
Description
time it takes to complete 8-foot up and go
Time Frame
baseline, 3 months, 6 months
Title
Change in 30 second chair stands
Description
number of chair stands done in 30 seconds
Time Frame
baseline, 3 months, 6 months
Title
Change in dietary protein intake
Description
3-day food record
Time Frame
baseline, 3 months, 6 months
Title
Change in calorie intake
Description
3-day food record
Time Frame
baseline, 3 months, 6 months
Title
Change in Bone Mineral Density
Description
DEXA
Time Frame
Baseline and 6-months
Title
Change in sleep
Description
Pittsburgh sleep quality index
Time Frame
baseline, 3 months, 6 months
Title
Change in depression
Description
Center for Epidemiologic Studies Depression Scale
Time Frame
baseline, 3 months, 6 months
Title
Change in hand grip strength
Description
Jamar Hand Dynamometer
Time Frame
baseline, 3 months, 6 months
Title
Change in physical activity
Description
Community Health Activities Model Program for Seniors (CHAMPS)
Time Frame
baseline, 3 months, 6 months
Title
Change in physical activity
Description
Actigraph - accelerometer
Time Frame
Baseline, 3 months, 6 months
Title
Change in quality of life
Description
SF-36
Time Frame
Baseline, 3 months, 6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: BMI >30; SPPB score of ≥4 to <10; GFR <45 mL/min Exclusion Criteria: Body weight >495 lbs. (BodPod limits); estimated glomerular filtration rates (eGFR) less than 45 mL/min; symptomatic cardiac disease; receiving chemotherapy; hemophilia; presence of unstable or symptomatic life-threatening illness; neurological disease or disorder causing functional impairments; inability to walk, dementia; prescription weight loss medications; use of monamine oxidase inhibitors (MAOIs); or primary medical provider advises against participation.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Connie Bales, PhD, RD
Organizational Affiliation
Duke University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Duke University Medical Center
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27710
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
33719918
Citation
Miller MG, Porter Starr KN, Rincker J, Orenduff MC, McDonald SR, Pieper CF, Fruik AR, Lyles KW, Bales CW. Rationale and Design for a Higher (Dairy) Protein Weight Loss Intervention That Promotes Muscle Quality and Bone Health in Older Adults with Obesity: A Randomized, Controlled Pilot Study. J Nutr Gerontol Geriatr. 2021 Apr-Jun;40(2-3):150-170. doi: 10.1080/21551197.2021.1896615. Epub 2021 Mar 13.
Results Reference
derived

Learn more about this trial

An Enhanced Protein (Dairy) Weight Loss Intervention for Dynapenic Obesity: Impact on Muscle Quality and Composition

We'll reach out to this number within 24 hrs